Mechanism-based organization of neural networks to emulate systems biology and pharmacology models

被引:1
|
作者
Mann, John [1 ]
Meshkin, Hamed [1 ]
Zirkle, Joel [1 ]
Han, Xiaomei [1 ]
Thrasher, Bradlee [1 ]
Chaturbedi, Anik [1 ]
Arabidarrehdor, Ghazal [1 ]
Li, Zhihua [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Div Appl Regulatory Sci, Off Clin Pharmacol,Off Translat Sci, WO Bldg 64 Rm 2084,10903 New Hampshire Ave, Silver Spring, MD 20993 USA
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
BUPRENORPHINE; GO;
D O I
10.1038/s41598-024-59378-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Deep learning neural networks are often described as black boxes, as it is difficult to trace model outputs back to model inputs due to a lack of clarity over the internal mechanisms. This is even true for those neural networks designed to emulate mechanistic models, which simply learn a mapping between the inputs and outputs of mechanistic models, ignoring the underlying processes. Using a mechanistic model studying the pharmacological interaction between opioids and naloxone as a proof-of-concept example, we demonstrated that by reorganizing the neural networks' layers to mimic the structure of the mechanistic model, it is possible to achieve better training rates and prediction accuracy relative to the previously proposed black-box neural networks, while maintaining the interpretability of the mechanistic simulations. Our framework can be used to emulate mechanistic models in a large parameter space and offers an example on the utility of increasing the interpretability of deep learning networks.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Massive computational acceleration by using neural networks to emulate mechanism-based biological models
    Wang, Shangying
    Fan, Kai
    Luo, Nan
    Cao, Yangxiaolu
    Wu, Feilun
    Zhang, Carolyn
    Heller, Katherine A.
    You, Lingchong
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [2] Massive computational acceleration by using neural networks to emulate mechanism-based biological models
    Shangying Wang
    Kai Fan
    Nan Luo
    Yangxiaolu Cao
    Feilun Wu
    Carolyn Zhang
    Katherine A. Heller
    Lingchong You
    Nature Communications, 10
  • [3] Exploration of differences between mechanism-based PK/PD and systems pharmacology models
    Demin, Oleg
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S73 - S73
  • [4] Deriving mechanism-based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
    Falkenhagen, Undine
    Knoechel, Jane
    Kloft, Charlotte
    Huisinga, Wilhelm
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (04): : 432 - 443
  • [5] CASCADE PROCESS MODELING WITH MECHANISM-BASED HIERARCHICAL NEURAL NETWORKS
    Cong, Qiumei
    Yu, Wen
    Chai, Tianyou
    INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, 2010, 20 (01) : 1 - 11
  • [6] Reduction of quantitative systems pharmacology models using artificial neural networks
    Derbalah, Abdallah
    Al-Sallami, Hesham S.
    Duffull, Stephen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2021, 48 (04) : 509 - 523
  • [7] Reduction of quantitative systems pharmacology models using artificial neural networks
    Abdallah Derbalah
    Hesham S. Al-Sallami
    Stephen B. Duffull
    Journal of Pharmacokinetics and Pharmacodynamics, 2021, 48 : 509 - 523
  • [8] Diversity of mechanism-based pharmacodynamic models
    Mager, DE
    Wyska, E
    Jusko, WJ
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 510 - 518
  • [9] Diversity of mechanism-based pharmacodynamic models
    Jusko, WJ
    DRUG METABOLISM REVIEWS, 2003, 35 : 21 - 21
  • [10] Mechanism-based inhibitors - the new phenomenon in enzymology and biology
    Pec, P
    Frebort, I
    Sebela, M
    CHEMICAL PAPERS, 1998, 52 : 331 - 331